BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37020850)

  • 1. Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
    Chen J; Ma N; Sun M; Chen L; Yao Q; Chen X; Lin C; Lu Y; Lin Y; Lin L; Fan X; Chen Y; Wu J; He H
    PeerJ; 2023; 11():e15084. PubMed ID: 37020850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
    Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
    Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MRI at 3T in Endometrial Cancer: Correlation of Apparent Diffusion Coefficient with Histopathological Prognostic Parameters.
    Ozturk M; Kalkan C; Danaci M; Kefeli M
    J Coll Physicians Surg Pak; 2021 Dec; 31(12):1399-1405. PubMed ID: 34794277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
    Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
    Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texture Analysis of Apparent Diffusion Coefficient Maps in Cervical Carcinoma: Correlation with Histopathologic Findings and Prognosis.
    Yamada I; Oshima N; Miyasaka N; Wakana K; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Kobayashi D
    Radiol Imaging Cancer; 2020 May; 2(3):e190085. PubMed ID: 33778713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of menstrual status and pathological type on the apparent diffusion coefficient in cervical cancer: a primary study.
    Dong Y; Dong RT; Zhang XM; Song QL; Yu T; Hong Luo Y
    Acta Radiol; 2021 Mar; 62(3):430-436. PubMed ID: 32536261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 14. MRI-based radiomics and ADC values are related to recurrence of endometrial carcinoma: a preliminary analysis.
    Zhang K; Zhang Y; Fang X; Dong J; Qian L
    BMC Cancer; 2021 Nov; 21(1):1266. PubMed ID: 34819042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
    Wang R; Xiao Y; Ma L; Wu Z; Xia H
    Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Acta Radiol; 2020 Jun; 61(6):848-855. PubMed ID: 31615267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients.
    Chen J; Sun Y; Chen L; Zang L; Lin C; Lu Y; Lin L; Lin A; Dan H; Chen Y; He H
    PeerJ; 2021; 9():e11563. PubMed ID: 34268005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
    Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
    J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.